日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era

个性化医疗时代新型鞘脂类癌症疗法

Shaw, Jeremy; Costa-Pinheiro, Pedro; Patterson, Logan; Drews, Kelly; Spiegel, Sarah; Kester, Mark

Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKε To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection

鞘氨醇-1-磷酸裂解酶增强IKKε的活化,从而促进I型干扰素介导的针对甲型流感病毒感染的先天免疫反应

Vijayan, Madhuvanthi; Xia, Chuan; Song, Yul Eum; Ngo, Hanh; Studstill, Caleb J; Drews, Kelly; Fox, Todd E; Johnson, Marc C; Hiscott, John; Kester, Mark; Alexander, Stephen; Hahm, Bumsuk

Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine

靶向肿瘤微环境中的癌细胞:组合纳米医学的机遇与挑战

Linton, Samuel S; Sherwood, Samantha G; Drews, Kelly C; Kester, Mark

Microbe-independent entry of oomycete RxLR effectors and fungal RxLR-like effectors into plant and animal cells is specific and reproducible.

卵菌 RxLR 效应蛋白和真菌 RxLR 样效应蛋白以非微生物依赖的方式进入植物和动物细胞具有特异性和可重复性

Tyler Brett M, Kale Shiv D, Wang Qunqing, Tao Kai, Clark Helen R, Drews Kelly, Antignani Vincenzo, Rumore Amanda, Hayes Tristan, Plett Jonathan M, Fudal Isabelle, Gu Biao, Chen Qinghe, Affeldt Katharyn J, Berthier Erwin, Fischer Gregory J, Dou Daolong, Shan Weixing, Keller Nancy P, Martin Francis, Rouxel Thierry, Lawrence Christopher B